(redirected from carcinoembryonic)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to antigen

any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)

References in periodicals archive ?
Further key findings from the study suggest: Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.
2 [down arrow] Tumor biomarkers Carcinoembryonic 2.
Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific antitumor immune responses utilizing macrophage mediated antigen presentation.
These are human intestinal epithelial cells which produce the secretory component of immunoglobulin A and carcinoembryonic antigen.
Carcinoembryonic antigen (CEA), cancer antigen (CA 199) and alpha-fetoprotein levels were normal.
The COST trial follow-up protocol included physical examination, including checking for recurrence at wound sites, plus carcinoembryonic antigen (CEA) testing every 3 months for the first year and then every 6 months for 5 years; chest x-ray every 6 months for 2 years and then annually; and colon evaluation, including colonoscopy or colon radiography, annually for the first year and then every 3 years if the colon was free of neoplasms; and computed tomography (CT) of the abdomen at the physician's discretion.
The ability of the biosensor to detect carcinoembryonic antigen (CEA) using the 40 nm gold nanoparticles was also studied.
In such equivocal cases, immunostaining for carcinoembryonic antigen or cytokeratin 7 may help identify glandular foci and thereby differentiate between the two entities, she noted.
A tumor marker panel consisting of prostate specific antigen (PSA), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9) and alpha fetoprotein (AFP) showed a mildly elevated PSA and CA 19-9.
After 6 weeks of anticancer therapy (7 weeks after tularemia), the patient's carcinoembryonic antigen decreased substantially.
CEA stands for carcinoembryonic antigen, a substance normally found only in babies developing within the womb.
Morris Plains, NJ) reported the issuance of United States Patent 6,676,924, covering a specific humanized antibody to carcinoembryonic antigen (CEA) that is attached to a therapeutic agent.